向EFHD2抑制干扰素γ信号传递,并改善非酒精性脂肪肝炎

Jiang-Tao Fu1, Jian Liu2, Wen-Bin Wu1

  • 1The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University/Second Military Medical University, Shanghai, China.

Journal of hepatology
|April 26, 2024
PubMed
概括

EF手域家族成员D2 (EFHD2) 通过促进炎症和干扰素γ信号传递,驱动非酒精性脂肪肝炎 (NASH). 用一种新来向EFHD2显示出NASH治疗的治疗前景.